Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) General Information
Description
A patent right for nucleic acid molecules inducing RNA interference located in Suwon, South Korea.
Contact Information
Corporate Office
- Suwon
- South Korea
Corporate Office
- Suwon
- South Korea
Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) FAQs
-
Where is Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) headquartered?
Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) is headquartered in Suwon, South Korea.
-
What industry is Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) in?
Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)’s primary industry is Buildings and Property.
-
Is Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) a private or public company?
Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) is a Private company.
-
What is the current valuation of Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)?
The current valuation of Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) is .
-
What is Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)’s current revenue?
The current revenue for Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) is .
-
Who are Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)’s investors?
Sungkyunkwan University has invested in Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference).
-
When was Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) acquired?
Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) was acquired on 30-Aug-2018.
-
Who acquired Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference)?
Sungkyunkwan University (Patent Right for Nucleic Acid Molecules Inducing RNA Interference) was acquired by Olix Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process